“Molecular Docking Studies FDA Approved Quercetin Inhibitory Potential of ATP Synthase F0F1 Subunit Beta from Streptococcus Mutans”. MSW Management Journal, vol. 36, no. 2, May 2026, pp. 1394-7, https://doi.org/10.7492/xadsj448.